<DOC>
	<DOCNO>NCT01208974</DOCNO>
	<brief_summary>Overall rationale : Prophylactic NAC irradiation nipple-areola spar mastectomy immediate reconstruction patient ductal carcinoma in-situ invasive breast cancer allow good cosmesis patient 's satisfaction . Study design : Phase I trial assess safety , feasibility toxicity prophylactic NAC irradiation nipple-areola spar mastectomy immediate reconstruction patient ductal carcinoma in-situ invasive breast cancer . Primary objective : To determine recommended phase I dose post-operative prophylactic NAC irradiation . Secondary objective : To provide extensive descriptive data regard NAC-sparing surgery reconstruction , include surgeon experience patient evaluation cosmetic result . Survival recurrence assess . Study size : Between 12 18 patient enrolled phase I study .</brief_summary>
	<brief_title>Nipple-Areola Complex ( NAC ) Irradiation After Nipple-Sparing Mastectomy Reconstruction</brief_title>
	<detailed_description>- The use NAC-sparing mastectomy follow postoperative NAC ( nipple-areola complex ) external beam radiotherapy select patient early stage invasive in-situ breast cancer technically feasible acceptable complication rate . - The cosmetic result NAC-sparing mastectomy follow postoperative external beam radiotherapy NAC well comparable Skin Sparing Mastectomy . - The local control rate NAC expect NAC spar mastectomy without postoperative radiotherapy . - The patient 's satisfaction NAC-sparing mastectomy follow postoperative NAC external beam radiotherapy well Skin Sparing Mastectomy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Ductal</mesh_term>
	<criteria>Patients must histologically confirm insitu invasive breast carcinoma . Tis , T1 , T2 invasive noninvasive carcinoma breast ; lesion le 4 cm . Unifocal , multifocal multicentric breast cancer remove nipple spar mastectomy negative surgical margin . No extensive intraductal component patient distant metastasis . Patients must &gt; 18 year age . No concomitant history nipple discharge skin involvement . No prior history malignancy ( less 5 year prior study entry ) , except nonmelanomatous skin cancer . No prior history radiation chest . No collagenous disease ( systemic lupus erythematosis , scleroderma , dermatomyositis ) No previous nonhormonal therapy include radiation chemotherapy current breast cancer . No patient Paget 's disease nipple . No patient coexist medical condition life expectancy &lt; 2 year . No pregnant lactate woman . ECOG 0 2 . Signed studyspecific inform consent form prior study entry . Retroareolar breast cancer lesion within one cm , depth skin surface . Concomitant history nipple discharge skin involvement . Patient distant metastasis . Patient extensive intraductal carcinoma . Any previously irradiate ipsilateral breast cancer . Patients Paget 's disease nipple . Patients collagenous disease , systemic lupus erythematosis , scleroderma dermatomyositis . Other malignancy , except nonmelanomatous skin cancer , less 5 year prior participation study . Patients pregnant lactate due potential exposure fetus RT unknown effect RT lactate female . Positive surgical margin follow nipple spar mastectomy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Nipple Area Complex</keyword>
	<keyword>Mastectomy</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Nipple-Sparing</keyword>
	<keyword>Breast Reconstruction</keyword>
</DOC>